NDC 86024-007 - FISH FLEX FORTE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 86024-007
- Package NDCs from labels
- 86024-007-30, 86024-007-12, 86024-007-00
- Manufacturer
- Thomas Labs, LLC | LUPIN LIMITED
- Effective date
- 2017-01-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| FISH FLEX FORTE - Thomas Labs, LLC | LUPIN LIMITED | Thomas Labs, LLC | LUPIN LIMITED | 2017-01-24 | OTC ANIMAL DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | FISH FLEX FORTE (CEPHALEXIN) CAPSULE [THOMAS LABS, LLC] | 1 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | FISH FLEX FORTE (CEPHALEXIN) CAPSULE [THOMAS LABS, LLC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | 6e5f9616-ddf2-19c4-e053-2991aa0a372a | 2024-07-18 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | ada33464-b416-9ac6-e053-2a95a90af787 | 2024-07-17 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | ade02343-3e4b-b1f1-e053-2995a90ac5fe | 2024-07-17 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | a33280d4-7caf-f74b-e053-2a95a90a90c3 | 2024-07-17 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Asclemed USA, Inc | 945552cb-90e4-41fb-afe2-8ee8785e94da | 2024-07-17 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | 3fcb3f88-9dfc-444d-952a-1d1967720525 | 2024-06-28 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Asclemed USA, Inc. | 4eb58a7e-1c92-4be3-b702-e522e0fbf425 | 2024-06-21 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Asclemed USA, Inc. | 20f8cc57-231c-4d36-a209-ff9e5735d65c | 2024-06-20 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | 90a76d24-e5a9-9000-e053-2a95a90ae8af | 2024-06-19 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | 6ac71dc8-7f86-60c5-e053-2a91aa0a2a7e | 2024-06-10 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | 6be20569-df34-04d9-e053-2991aa0a94fd | 2024-06-10 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | 728c5212-dbd8-8df5-e053-2a91aa0a9579 | 2024-06-10 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | 681c235f-6dee-1401-e053-2991aa0addc0 | 2024-06-07 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | 73920373-b45d-45d6-b183-d962467dde36 | 2024-05-24 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | fc426d0d-9774-4189-8d83-89aa85d926bb | 2024-05-22 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | 712a6789-7aab-4114-ae92-d1c7686c6b96 | 2024-05-16 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | 5b7666f3-4014-45ce-8387-3298d9fe6d25 | 2024-05-07 | Warnings, Adverse reactions | OBN7UDS42Y |
| cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | 141bd050-5dfc-68fa-e063-6394a90a6d86 | 2024-03-20 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | ADVANCED RX PHARMACY OF TENNESSEE, LLC | af49507d-254f-296d-e053-2a95a90ad263 | 2024-03-12 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 4fccce5a-4e39-46cd-976a-32ff71189520 | 2024-03-08 | Warnings, Adverse reactions | OBN7UDS42Y |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.